Literature DB >> 11020354

Downregulation of CXCR4 gene expression in primary human endothelial cells following infection with E1(-)E4(+) adenovirus gene transfer vectors.

R Ramalingam1, S Worgall, S Rafii, R G Crystal.   

Abstract

Infection of human endothelial cells with first-generation E1(-)E4(+) adenovirus (Ad) vectors leads to prolonged cell survival and changes in the cell phenotype to a more quiescent stage. Based on the concept that the CXCR4, the receptor for the endothelial chemoattractant stromal-derived factor-&alpha (SDF-alpha), is constitutively expressed by quiescent, resting endothelial cells, the present study analyzes the effect of Ad vector infection on CXCR4 expression and SDF-alpha responses of human umbilical vein endothelial cells (HUVEC). CXCR4 transcripts were markedly downregulated in E1(-)E4(+) Ad-infected cells 48 h following infection, but not in uninfected control cells or when the cells were infected with an E1(-)E4(-) Ad vector. Analysis of surface CXCR4 expression by flow cytometry demonstrated marked reduction of the CXCR4 receptor on cells infected with E1(-)E4(+) Ad compared to uninfected control cells or E1(-)E4(-) Ad-infected cells. Infection of other cell types which express CXCR4, such as dendritic cells and myeloma cells, did not exhibit CXCR4 receptor downregulation following infection with E1(-)E4(+) Ad. Consistent with the observed downregulation of CXCR4 mRNA and surface protein, infection of the endothelial cells with an E1(-)E4(+) Ad rendered the cells unresponsive to the chemoattractant SDF-alpha compared to naive or E1(-)E4(-) Ad-infected cells. Together, the data suggest that first-generation Ad vectors, likely the E4 region, modify the ability of endothelial cells to respond to at least one important chemoattractant.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11020354     DOI: 10.1006/mthe.2000.0131

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  3 in total

1.  Neural stem cell-based cell carriers enhance therapeutic efficacy of an oncolytic adenovirus in an orthotopic mouse model of human glioblastoma.

Authors:  Atique U Ahmed; Bart Thaci; Nikita G Alexiades; Yu Han; Shuo Qian; Feifei Liu; Irina V Balyasnikova; Ilya Y Ulasov; Karen S Aboody; Maciej S Lesniak
Journal:  Mol Ther       Date:  2011-05-31       Impact factor: 11.454

2.  Helper-dependent adenoviral vectors are superior in vitro to first-generation vectors for endothelial cell-targeted gene therapy.

Authors:  Rowan Flynn; Joshua M Buckler; Chongren Tang; Francis Kim; David A Dichek
Journal:  Mol Ther       Date:  2010-08-31       Impact factor: 11.454

3.  Synergistic effect of HIF-1alpha gene therapy and HIF-1-activated bone marrow-derived angiogenic cells in a mouse model of limb ischemia.

Authors:  Sergio Rey; KangAe Lee; C Joanne Wang; Kshitiz Gupta; Shaoping Chen; Alexandra McMillan; Nupura Bhise; Andre Levchenko; Gregg L Semenza
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-30       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.